Influenza A virus (FluA), influenza B virus (FluB) and respiratory syncytial virus (RSV) illnesses increase hospitalizations during seasonal epidemics.

To determine the utility of the Simplexa FluA/B & RSV Direct Assay (Direct Flu/RSV) and its impact on oseltamivir use, we offered this assay to emergency department (ED) patients with influenza-like illness.

Utilization of the Direct Flu/RSV provided a turnaround time (TAT) of 2 hours. Compared to the flu season prior to implementation of the Direct Flu/RSV, clinicians were more likely to prescribe 5 days of oseltamivir therapy for Direct Flu/RSV-positive patients in comparison to those with a negative test.

Use of Direct Flu/RSV provides results rapidly, which leads to more appropriate use of oseltamivir. The ease of use of this assay and quick TAT allows for prompt decision-making, which is essential for patient care and effective disease control during the influenza season.


Article metrics loading...

Loading full text...

Full text loading...



  1. Centers for Disease Control and Prevention 2017; Who is at risk from flu. https://www.cdc.gov/flu/about/disease/high_risk.htm
  2. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352:1749–1759 [View Article][PubMed]
    [Google Scholar]
  3. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360:588–598 [View Article][PubMed]
    [Google Scholar]
  4. Centers for Disease Control and Prevention Influenza Activity- US October 2-December 17 2016. Morbid Mortal Weekly Rep 2016; 65:5051
    [Google Scholar]
  5. Selvaraju SB, Bambach AV, Leber AL, Patru MM, Patel A et al. Comparison of the Simplexa™ Flu A/B & RSV kit (nucleic acid extraction-dependent assay) and the Prodessa ProFlu+™ assay for detecting influenza and respiratory syncytial viruses. Diagn Microbiol Infect Dis 2014; 80:50–52 [View Article][PubMed]
    [Google Scholar]
  6. Centers for Disease Control and Prevention Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus-US, 2009. Morbid Mortal Weekly Rep 2009; 58:826–829
    [Google Scholar]
  7. Hindiyeh M, Kolet L, Meningher T, Weil M, Mendelson E et al. Evaluation of Simplexa Flu A/B & RSV for direct detection of influenza viruses (A and B) and respiratory syncytial virus in patient clinical samples. J Clin Microbiol 2013; 51:2421–2424 [View Article][PubMed]
    [Google Scholar]
  8. Simplexa Flu A/B & RSV Package Insert, Focus Diagnostics 2016 Cypress, California: https://www.focusdx.com/pdfs/pi/US/MOL2600.pdf
  9. Pierce VM, Elkan M, Leet M, Mcgowan KL, Hodinka RL et al. Comparison of the Idaho Technology FilmArray system to real-time PCR for detection of respiratory pathogens in children. J Clin Microbiol 2012; 50:364–371 [View Article][PubMed]
    [Google Scholar]
  10. May LS, Griffin BA, Bauers NM, Jain A, Mitchum M et al. Emergency department chief complaint and diagnosis data to detect influenza-like illness with an electronic medical record. West J Emerg Med 2010; 11:1–9[PubMed]
    [Google Scholar]
  11. Feemster KA, Odeniyi FM, Localio R, Grundmeier RW, Coffin SE et al. Surveillance for healthcare-associated influenza-like illn3ess in pediatric clinics: validity of diagnosis codes for case identification. Infect Control Hosp Epidemiol 2016; 37:1247–1250 [View Article][PubMed]
    [Google Scholar]

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error